Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03564665 · ClinicalTrials.gov registry record · NA
Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes.
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03564665: Completed NA study, sponsored by Mayo Clinic.
NCT03564665 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03564665, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The goal of this study is to further evaluate the effect of magnesium on the symptoms of menopause, specifically vasomotor symptoms (VMS) in breast cancer patients and/or women at an elevated risk of breast cancer.
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT 400mg Magnesium Glycinate BID
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2018-07-24 |
| Est. Completion | 2021-04-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03564665
The ClinicalTrials.gov registry entry for NCT03564665 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT03564665 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03564665 about?
NCT03564665 is a clinical study titled "Investigating Magnesium Glycinate in Structure/Function Role of Hot Flashes.". The goal of this study is to further evaluate the effect of magnesium on the symptoms of menopause, specifically vasomotor symptoms (VMS) in breast cancer patients and/or women at an elevated risk of breast cancer.
What is the current status of trial NCT03564665?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2018-07-24. Estimated completion is 2021-04-10.
What interventions are being tested in trial NCT03564665?
The interventions under investigation include: Placebo (OTHER), 400mg Magnesium Glycinate BID (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03564665?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.